NEW YORK, Nov. 12 – The Federal Trade Commission has approved PerkinElmer's proposed acquisition of Packard BioScience and the deal is now set to close on November 13, PerkinElmer said Monday.

"We will now move quickly to integrate these highly complementary businesses into the world's premier provider of drug discovery solutions," Grergory Summe, CEO of PerkinElmer, said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.

A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.

The New York Times writes about the appearance of mosaicism in healthy people.

In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.